Form D — Q-Immune, Inc.
0002155816-26-000001 · filed Sep 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,000,000
- Total sold
- $25,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Q-Immune, Inc.
- CIK
- 2155816
- Entity
- Corporation
- Jurisdiction
- WASHINGTON
- Year incorporated
- 2025
- Address
- 2607 NE 100TH ST
SEATTLE, WA 98125 - Phone
- 206-914-1995
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Cameron McCann · Executive OfficerSEATTLE, WA Find on LinkedIn ↗
-
Stephen Paucha Smith · Executive OfficerSEATTLE, WA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗